Baseline and early changes in eosinophil count and neutrophil-to-eosinophil ratio predict outcomes in metastatic renal cell carcinoma treated with nivolumab.

Sci Rep · 2025 · PMC12824351 · PMID 41423480

Europe PMC DOI

hedged sentence

0.0860

closest p · 1.7× alpha

0.0860

boldest claim

The sentences

a nonsignificant trendp = 0.086so close (0.05 < p ≤ 0.1)

In particular, these patients more frequently presented with poorer ECOG performance status (p-values 0.002 to < 0.001) and higher IMDC risk categories (p-values 0.006 to < 0.001, with a nonsignificant trend for ΔAEC, p = 0.086).

also in 5,406 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.